OBR Daily Commentary

forumImage

Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers

(KHN) July 31, 2020 - Early in the pandemic, insurers expected the costs of treating COVID-19 would vastly increase medical spending. Instead, non-COVID care has plummeted and insurers have pocketed the result.

William McGivney, PhD (Posted: August 04, 2020)

quotesIt is interesting to see "record profits" for managed care companies in the face of the Covid-19 Pandemic. The referenced article and press releases from the managed care companies tell us what we already know; that health insurer claims payments were substantially lower in the second quarter of 2020 due to fewer surgeries, decreased outpatient visits, canceled doctors’ visits, delayed screenings etc. In some cases, payer profits doubled. While the article focuses on heavily regulated California where premium increases for 2021 are projected to be moderate, one would hope that given the sad irony of the “Payer Pandemic Windfall” so far in 2020, payers will work to truly moderate or eliminate premium increases for 2021. Not so, instead the article reports on a projected premium increase of 13.8% being sought in New York State by one national insurer. Television now has advertisements by car insurance companies emphasizing decreases in rates for 2020 and the return of some premium monies to their subscribers. The referenced article here points out that one national health insurer is providing premium credits and cost-sharing waivers. One would hope that such return of monies would go beyond contractual requirements negotiated by large self-insured employers powerful enough to do so. Then, we filter down to providers who at almost every level (e.g., hospitals, community practices) are losing substantial sums of revenue that remain in the pockets and/or banks of managed care companies. The referenced article indicates the distinct possibility of contentious negotiations between providers and payers for 2021 and beyond. And so it goes, as we battle the most awful and dangerous Pandemic threat to both individual existence and to the existence of our society, we continue to traverse The Road to Kick Ass-Health Care. quotes

Read Article arrow
Add Comment 1 Comment
forumImage

Trump Expected To Sign Drug Pricing Executive Orders Friday, Angering Pharma

(Washington Post) July 24, 2020 - President Trump is expected to sign three health care executive orders on Friday — two of which target the pharmaceutical industry on drug pricing — even as the administration depends on it to develop vaccines to help end the coronavirus pandemic.

Dean Gesme, MD (Posted: July 26, 2020)

quotesTrump gave just Congress and manufacturers 30 days to develop and pass a Part B Medicare drug acquisition Bill. If not accomplished, then Trump’s Executive order of July 24, 2020 will implement CMS’ International Pricing Index to slash Part B drug prices. Highly disruptive to oncology providers of care!quotes

Read Article arrow
Add Comment 1 Comment
forumImage

Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer

(NCCN) July 13, 2020 - The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the NCCN Distress Thermometer has been translated into 46 languages. This free resource helps providers worldwide identify and address the multifactorial aspects of distress cancer patients can experience.

William McGivney, PhD (Posted: July 19, 2020)

quotesIt is with fondness and a smile that I read the story about the distress thermometer now being available in 46 languages to help manage and improve the psycho-social well-being of patients with cancer. I joined the NCCN as CEO and the fourth employee in January of 1997. The NCCN Guidelines were in an embryonic stage. There was one NCCN doctor who early on saw the tremendous potential of what the NCCN was doing in terms of Guidelines to drive a standard of cancer care. Early on in my NCCN career, I received a call from a psychiatrist at Memorial Sloan Kettering. It was Jimmie Holland MD, the inaugural Psychiatrist-in-Chief at MSK. Dr. Holland cogently put forth and emphasized the need that the psycho-social needs of patients be evaluated and addressed from diagnosis through survivorship. Dr. Holland championed her concept of using “distress” as the encompassing description of a set of characteristics that deserved the attention of clinicians. While gentle and almost “grandmotherly” (in a very good way) in her approach, Dr Holland was indomitable in her drive to provide the best comprehensive care for patients with cancer. Dr. Holland worked with tireless dedication to help to optimize the psycho-social well-being of patients. Indeed, by 1999, she had achieved her goal, in part, with the publication of the NCCN Guideline for the Management of Psychosocial Distress. There were many key NCCN figures who contributed to the attainment of Dr. Holland’s goal. Dr. Holland did not stop there. Now, but twenty years later, the work of Dr. Holland drives the comprehensive care of patients across the globe. I smile remembering a person whom, with great rarity, I describe as a "Saint among us"! Dr. Jimmie Holland died in 2017 at the age of 89. God Bless you Dr. Holland! quotes

Read Article arrow
Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Associate Clinical Professor, Medical Oncology Executi...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics Professo...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology P...

member photo
Stephen M. Schleicher, M.D., MBA

Community Oncology, Medical Oncologist, OneOncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...